Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD339 Mouse anti-Human, PE, Clone: MHJ1-152, BD Pharmingen™

Catalog No. BDB565495 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB565495 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB565495 Supplier BD Biosciences Supplier No. 565495
Only null left
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

CD339 Monoclonal antibody specifically detects CD339 in Human samples. It is validated for Flow cytometry.
TRUSTED_SUSTAINABILITY

Specifications

Antigen CD339
Applications Flow Cytometry
Classification Monoclonal
Clone MHJ1-152
Concentration 0.2mg/mL
Conjugate PE
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Gene Alias Jagged-1, hJ1, CD339, JAG1, JAGL1
Host Species Mouse
Immunogen Human JAG1 Transfected Cell Line
Quantity 50 μg
Regulatory Status RUO
Research Discipline Cell Biology
Primary or Secondary Primary
Target Species Human
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with R-PE under optimum conditions and unconjugated antibody and free PE were removed.
Form Purified
Isotype IgG1 κ
Show More Show Less

For Reseach Use Only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.